chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chest pain
Clinical narrative: Chest pain; back pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain) and BACK PAIN (back pain) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included DILTIAZEM, PHENYTOIN (DILANTIN [PHENYTOIN]), PHENOBARBITAL (FENOBARB), SOTALOL, LEVOTHYROXINE and WARFARIN for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced CHEST PAIN (Chest pain) and BACK PAIN (back pain). On 17-Feb-2021, CHEST PAIN (Chest pain) and BACK PAIN (back pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site is hot to the touch an a little swollen; Injection site is hot to the touch an a little swollen; Tired; fever; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE WARMTH (Injection site is hot to the touch an a little swollen), PYREXIA (fever), VACCINATION SITE SWELLING (Injection site is hot to the touch an a little swollen) and FATIGUE (Tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concurrent medical conditions included Allergy to antibiotic (CEFTIN). Concomitant products included LORAZEPAM and CITALOPRAM for Anxiety, ATORVASTATIN for Cholesterol, TEMAZEPAM for Sleep disorder NOS, ACETYLSALICYLIC ACID (BABY ASPIRIN) and CALCIUM CHLORIDE, GLYCINE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE (CENTRAMIN) for an unknown indication.   On 30-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced PYREXIA (fever). On an unknown date, the patient experienced VACCINATION SITE WARMTH (Injection site is hot to the touch an a little swollen), VACCINATION SITE SWELLING (Injection site is hot to the touch an a little swollen) and FATIGUE (Tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, VACCINATION SITE WARMTH (Injection site is hot to the touch an a little swollen), PYREXIA (fever), VACCINATION SITE SWELLING (Injection site is hot to the touch an a little swollen) and FATIGUE (Tired) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown)   This case was linked to MOD-2021-251834 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 03-Feb-2021: Reporter details updated, new events updated, concomitant medication and treatment details were updated. On 08-Jul-2021: Significant follow-up appended
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Myalgia, Pain in extremity
Clinical narrative: painful arm; headache; sore arm; flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), PAIN IN EXTREMITY (painful arm), HEADACHE (headache) and MYALGIA (sore arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (sore arm). On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (painful arm) and HEADACHE (headache). On 15-Jan-2021, INFLUENZA LIKE ILLNESS (flu like symptoms) and MYALGIA (sore arm) had resolved. At the time of the report, PAIN IN EXTREMITY (painful arm) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: warm to the touch at the site of injection; itchiness at the site of injection; Redness at site of injection; Bad headache; Sore at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (warm to the touch at the site of injection), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at site of injection), HEADACHE (Bad headache) and VACCINATION SITE PAIN (Sore at the site of injection) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (warm to the touch at the site of injection), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at site of injection), HEADACHE (Bad headache) and VACCINATION SITE PAIN (Sore at the site of injection). The patient was treated with CORTISONE ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (warm to the touch at the site of injection), VACCINATION SITE PRURITUS (itchiness at the site of injection), VACCINATION SITE ERYTHEMA (Redness at site of injection), HEADACHE (Bad headache) and VACCINATION SITE PAIN (Sore at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site reaction, Vaccination site erythema, Vaccination site pruritus
Clinical narrative: firmness at injection site; itching at injection site; red at injection site, pink at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE REACTION (firmness at injection site), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (red at injection site, pink at injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031420A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included METFORMIN, GLIPIZIDE, METOPROLOL, LISINOPRIL and WARFARIN for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced INJECTION SITE REACTION (firmness at injection site), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (red at injection site, pink at injection site). At the time of the report, INJECTION SITE REACTION (firmness at injection site), VACCINATION SITE PRURITUS (itching at injection site) and VACCINATION SITE ERYTHEMA (red at injection site, pink at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details was not reported by the reporter.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: tested positive with covid; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (tested positive with covid) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (tested positive with covid). At the time of the report, SARS-COV-2 TEST POSITIVE (tested positive with covid) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Malaise
Clinical narrative: dizziness; malaise; severe headaches; fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of DIZZINESS (dizziness), MALAISE (malaise), HEADACHE (severe headaches) and FATIGUE (fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), MALAISE (malaise), HEADACHE (severe headaches) and FATIGUE (fatigue). The patient was treated with OXITRIPTAN (TRIPTAN [OXITRIPTAN]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, DIZZINESS (dizziness), MALAISE (malaise), HEADACHE (severe headaches) and FATIGUE (fatigue) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Bodyaches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Bodyaches) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     Concurrent medical conditions included Back pain.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced MYALGIA (Bodyaches). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Myalgia, at an unspecified dose and frequency. At the time of the report, MYALGIA (Bodyaches) outcome was unknown.            Action taken with mRNA-1273 was not applicable. Concomitant medication details were not reported by the reporter.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Hypoaesthesia, Neck pain, Vaccination site pain
Clinical narrative: Pain in the injection arm; Pain in the neck; Numbness of the Face; Pain in the Shoulder; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Pain in the neck), HYPOAESTHESIA (Numbness of the Face), ARTHRALGIA (Pain in the Shoulder) and VACCINATION SITE PAIN (Pain in the injection arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced NECK PAIN (Pain in the neck), HYPOAESTHESIA (Numbness of the Face) and ARTHRALGIA (Pain in the Shoulder). On 02-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain in the injection arm). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) ongoing since an unknown date for Pain, at an unspecified dose and frequency. At the time of the report, NECK PAIN (Pain in the neck) and VACCINATION SITE PAIN (Pain in the injection arm) outcome was unknown and HYPOAESTHESIA (Numbness of the Face) and ARTHRALGIA (Pain in the Shoulder) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Depression, Feeling abnormal
Clinical narrative: Brainfog; depression; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Brainfog) and DEPRESSION (depression) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety and Depression.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced FEELING ABNORMAL (Brainfog) and DEPRESSION (depression). At the time of the report, FEELING ABNORMAL (Brainfog) and DEPRESSION (depression) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included unspecified medication for depression and anxiety. Treatment detail was not reported by the reporter.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: Tested positive for COVID-19 virus; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 virus) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 virus). At the time of the report, SARS-COV-2 TEST POSITIVE (Tested positive for COVID-19 virus) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test positive: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reporter by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Itching at injection site; Rash at injection site; Swelling at injection site; Pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE PAIN (Pain at injection site), VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE SWELLING (Swelling at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site). On 01-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE RASH (Rash at injection site) and VACCINATION SITE SWELLING (Swelling at injection site). The patient was treated with MULTIVITAMIN [VITAMINS NOS] ongoing since an unknown date at an unspecified dose and frequency. On 27-Jan-2021, VACCINATION SITE PAIN (Pain at injection site) had resolved. On 03-Feb-2021, VACCINATION SITE PRURITUS (Itching at injection site) had resolved. On 04-Feb-2021, VACCINATION SITE SWELLING (Swelling at injection site) had resolved. At the time of the report, VACCINATION SITE RASH (Rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter.   Reporter did not allow further contact
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Developed a large red mark on her arm the size of a lemon; Developed a large red mark on her arm the size of a lemon, itchy; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Developed a large red mark on her arm the size of a lemon) and INJECTION SITE PRURITUS (Developed a large red mark on her arm the size of a lemon, itchy) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Developed a large red mark on her arm the size of a lemon) and INJECTION SITE PRURITUS (Developed a large red mark on her arm the size of a lemon, itchy). On 25-Jan-2021, INJECTION SITE ERYTHEMA (Developed a large red mark on her arm the size of a lemon) and INJECTION SITE PRURITUS (Developed a large red mark on her arm the size of a lemon, itchy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, COVID-19, Headache, Pyrexia, Rhinorrhoea
Clinical narrative: feels like she got COVID but not yet tested for it.; loss of test; fever; headache; runny nose; This spontaneous case was reported by a consumer and describes the occurrence of RHINORRHOEA (runny nose), COVID-19 (feels like she got COVID but not yet tested for it.), AGEUSIA (loss of test), PYREXIA (fever) and HEADACHE (headache) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced RHINORRHOEA (runny nose) and HEADACHE (headache). On 20-Feb-2021, the patient experienced AGEUSIA (loss of test) and PYREXIA (fever). On an unknown date, the patient experienced COVID-19 (feels like she got COVID but not yet tested for it.). At the time of the report, RHINORRHOEA (runny nose), COVID-19 (feels like she got COVID but not yet tested for it.), AGEUSIA (loss of test), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: pain; redness; tired; swelling; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tired), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (pain) and VACCINATION SITE ERYTHEMA (redness) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced FATIGUE (tired), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (redness). On 23-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain). On 19-Feb-2021, FATIGUE (tired), VACCINATION SITE SWELLING (swelling) and VACCINATION SITE ERYTHEMA (redness) had resolved. At the time of the report, VACCINATION SITE PAIN (pain) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of myalgia (sore arm), chills, myalgia (muscle pain), pyrexia (fever) and fatigue in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. The occurrence of additional events detailed below. No medical history reported. On Feb 23, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced myalgia (sore arm), chills, myalgia (muscle pain), pyrexia (fever), fatigue and headache. At the time of the report, myalgia (sore arm) resolved; chills, pyrexia (fever) and fatigue outcome: unknown; myalgia (muscle pain): resolving; and headache: not resolved. Concomitant medication and treatment information not reported.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: severe adverse reaction to the first dose of the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE EVENT (severe adverse reaction to the first dose of the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE EVENT (severe adverse reaction to the first dose of the vaccine). At the time of the report, ADVERSE EVENT (severe adverse reaction to the first dose of the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site reaction, Vaccination site swelling
Clinical narrative: The affected area is about the size of a golf ball; Itching at injection site; Swelling at injection site; Hot and red at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (The affected area is about the size of a golf ball), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PAIN (Hot and red at injection site) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE REACTION (The affected area is about the size of a golf ball), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PAIN (Hot and red at injection site). At the time of the report, VACCINATION SITE REACTION (The affected area is about the size of a golf ball), VACCINATION SITE PRURITUS (Itching at injection site), VACCINATION SITE SWELLING (Swelling at injection site) and VACCINATION SITE PAIN (Hot and red at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication were not reported by the reporter. Treatment medication was not reported by the reporter.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Vaccination site pain
Clinical narrative: Swelling from above his shoulder to below his elbow; redness; Itching; Soreness to touch; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling from above his shoulder to below his elbow), VACCINATION SITE PAIN (Soreness to touch), ERYTHEMA (redness) and PRURITUS (Itching) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 027L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included AMLODIPINE, ATENOLOL and BENAZEPRIL HYDROCHLORIDE, HYDROCHLOROTHIAZIDE (BENAZEPRIL/HYDROCHLOROTHIAZIDE ACTAVIS) for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness to touch). On 20-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swelling from above his shoulder to below his elbow), ERYTHEMA (redness) and PRURITUS (Itching). At the time of the report, PERIPHERAL SWELLING (Swelling from above his shoulder to below his elbow), VACCINATION SITE PAIN (Soreness to touch), ERYTHEMA (redness) and PRURITUS (Itching) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Swelling
Clinical narrative: swelling in both thighs; swelling in both ankles; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (swelling in both thighs) and SWELLING (swelling in both ankles) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced PERIPHERAL SWELLING (swelling in both thighs) and SWELLING (swelling in both ankles). At the time of the report, PERIPHERAL SWELLING (swelling in both thighs) and SWELLING (swelling in both ankles) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity, Pyrexia
Clinical narrative: soreness in his arm; body aches; a slight fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in his arm), MYALGIA (body aches) and PYREXIA (a slight fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported adverse event).    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in his arm), MYALGIA (body aches) and PYREXIA (a slight fever). At the time of the report, PAIN IN EXTREMITY (soreness in his arm), MYALGIA (body aches) and PYREXIA (a slight fever) outcome was unknown.            No Concomitant information  provided. No Treatment information  provided
Sex: U
Vaccine: COVID19
Symptoms: Malaise
Clinical narrative: Got sick; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Got sick) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Got sick). At the time of the report, MALAISE (Got sick) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Adverse reaction after Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Adverse reaction after Moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No relevant concomitant medications reported. No relevant medical history was reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Adverse reaction after Moderna vaccine). At the time of the report, VACCINATION COMPLICATION (Adverse reaction after Moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment Medications were not provided by the reporter.   Reporter did not allow further contact; Reporter's Comments: not specific adverse event reported
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Arm became itchy; Rash on the back and upper arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on the back and upper arm) and PRURITUS (Arm became itchy) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No recorded medical history.).    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced RASH (Rash on the back and upper arm). On 06-Feb-2021, the patient experienced PRURITUS (Arm became itchy). In February 2021, RASH (Rash on the back and upper arm) had resolved. At the time of the report, PRURITUS (Arm became itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Concomitant information  provided. Treatment included Triamcinolone 1% on her skin for her symptom.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: arm sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm sore) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm sore). On 31-Jan-2021, PAIN IN EXTREMITY (arm sore) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided by reporter.  No treatment information was provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Energy increased, Therapeutic response unexpected
Clinical narrative: renewed energy; more energy than ever; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (renewed energy) and ENERGY INCREASED (more energy than ever) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 030L20A) for COVID-19 vaccination.     Concomitant products included ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), TURMERIC [CURCUMA LONGA RHIZOME] and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 07-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Feb-2021, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (renewed energy) and ENERGY INCREASED (more energy than ever). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (renewed energy) and ENERGY INCREASED (more energy than ever) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment was details included.
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Pyrexia
Clinical narrative: Chills; Fatigue; Fever of 100.7°C; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever of 100.7°C) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever of 100.7°C). At the time of the report, CHILLS (Chills), FATIGUE (Fatigue) and PYREXIA (Fever of 100.7°C) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, Body temperature: 100.7 degree centtigrade (High) 100.7.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment medications included ibuprofen and acetaminophen.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Myalgia, Pregnancy test, Ultrasound scan
Clinical narrative: Pregnant; Sore arm; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 27-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (2 to 3 drinks a week) in August 2020. Concurrent medical conditions included Anxiety (Stable and under control now) and Acid reflux (oesophageal). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and CALCIUM CARBONATE (TUMS ANTACID) for an unknown indication.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 07-Sep-2020 and the estimated date of delivery was 14-Jun-2021. On 24-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-fourth week of the pregnancy.  On 24-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Oct-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       On an unknown date, ultrasound was performed to check anatomy which came normal, genetic test (to check for spina bisida) was low risk and down syndrome test was at low risk. The estimated date of conception was 28 Sep 2020. She was 24 weeks and 3 days.  Treatment information was not reported
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Itching and a red ring at injection site; Itching and a red ring at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching and a red ring at injection site) and VACCINATION SITE ERYTHEMA (Itching and a red ring at injection site) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OLMESARTAN, APIXABAN (ELIQUIS) and METOPROLOL for an unknown indication.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching and a red ring at injection site) and VACCINATION SITE ERYTHEMA (Itching and a red ring at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itching and a red ring at injection site) and VACCINATION SITE ERYTHEMA (Itching and a red ring at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications included Claritin and antihistamine.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hypersensitivity, Type IV hypersensitivity reaction, Vaccination site induration
Clinical narrative: Delayed reaction; red area; firm underneath; sensitivity reaction; This spontaneous case was reported by a consumer and describes the occurrence of TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction), ERYTHEMA (red area), VACCINATION SITE INDURATION (firm underneath) and HYPERSENSITIVITY (sensitivity reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction), ERYTHEMA (red area), VACCINATION SITE INDURATION (firm underneath) and HYPERSENSITIVITY (sensitivity reaction). At the time of the report, TYPE IV HYPERSENSITIVITY REACTION (Delayed reaction), ERYTHEMA (red area), VACCINATION SITE INDURATION (firm underneath) and HYPERSENSITIVITY (sensitivity reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: sore arm; temperature; chills; body aches; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), PYREXIA (temperature), CHILLS (chills) and MYALGIA (body aches) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), PYREXIA (temperature), CHILLS (chills) and MYALGIA (body aches). At the time of the report, PAIN IN EXTREMITY (sore arm), PYREXIA (temperature), CHILLS (chills) and MYALGIA (body aches) had resolved.            No concomitant medications were provided.  No treatment information provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: soreness when she got the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (soreness when she got the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (soreness when she got the vaccine). At the time of the report, VACCINATION SITE PAIN (soreness when she got the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: torso rash; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of RASH (torso rash) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced RASH (torso rash). At the time of the report, RASH (torso rash) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment information was not reported.
Sex: M
Vaccine: COVID19
Symptoms: Bradykinesia, Chills, Injection site hypoaesthesia, Sluggishness
Clinical narrative: Some numbness in the left arm at the injection site; Felt sluggish; Slowness in the body; Chills; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HYPOAESTHESIA (Some numbness in the left arm at the injection site), SLUGGISHNESS (Felt sluggish), BRADYKINESIA (Slowness in the body) and CHILLS (Chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE HYPOAESTHESIA (Some numbness in the left arm at the injection site), SLUGGISHNESS (Felt sluggish), BRADYKINESIA (Slowness in the body) and CHILLS (Chills). At the time of the report, INJECTION SITE HYPOAESTHESIA (Some numbness in the left arm at the injection site), SLUGGISHNESS (Felt sluggish), BRADYKINESIA (Slowness in the body) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Limb discomfort, Oropharyngeal pain
Clinical narrative: throat is also a little bit sore; extremely exhausted; arm sore; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (arm sore), FATIGUE (extremely exhausted) and OROPHARYNGEAL PAIN (throat is also a little bit sore) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided).    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, the patient experienced LIMB DISCOMFORT (arm sore). On 22-Feb-2021, the patient experienced FATIGUE (extremely exhausted). On an unknown date, the patient experienced OROPHARYNGEAL PAIN (throat is also a little bit sore). On 21-Feb-2021, LIMB DISCOMFORT (arm sore) had resolved. At the time of the report, FATIGUE (extremely exhausted) and OROPHARYNGEAL PAIN (throat is also a little bit sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       The patient's medical history was unknown Concomitant medications reported included medications for condition probably colitis. No treatment provided
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site reaction, Injection site warmth, Pruritus
Clinical narrative: red area around the injection site; itchy; size of a 50-cent piece; warm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (red area around the injection site), PRURITUS (itchy), INJECTION SITE REACTION (size of a 50-cent piece) and INJECTION SITE WARMTH (warm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no medical history provided). Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, LOSARTAN and METOPROLOL for Blood pressure high, CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (red area around the injection site), PRURITUS (itchy), INJECTION SITE REACTION (size of a 50-cent piece) and INJECTION SITE WARMTH (warm). At the time of the report, INJECTION SITE ERYTHEMA (red area around the injection site), PRURITUS (itchy), INJECTION SITE REACTION (size of a 50-cent piece) and INJECTION SITE WARMTH (warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment provided patient is taking unknown water pill as conmed